News & Events

• January 1, 2017
  

  Total Kidney Volume Is a Prognostic Biomarker of Renal Function Decline and Progression to End-Stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease

  Perrone RD, Mouksassi MS, Romero K, Czerwiec FS, Chapman AB, Gitomer BY, Torres VE, Miskulin DC, Broadbent S, Marier JF. Total Kidney Volume Is a Prognostic Biomarker of Renal Function Decline and Progression to End-Stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease. Kidney International Reports. 2017 Jan.

• January 1, 2017
  

  Evaluating the Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ): Results from the quantitative pilot study

  Liepa AM, Bushnell DM, Atkinson TM, DeBusk K, McCarrier KP, Martin ML, et al. Evaluating the Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ): Results from the quantitative pilot study. Journal of Thoracic Oncology. 2017;12(1S):S666.

• January 1, 2017
  

  Preclinical Biomarker Qualification

  Sauer JM, Porter AC, Biomarker Programs, Predictive Safety Testing Consortium. Preclinical Biomarker Qualification. Experimental Biology and Medicine (Maywood, NJ). 2017 Jan 1.

• December 1, 2016
  

  Interpretation of verbal descriptors for response options commonly used in verbal rating scales in patient-reported outcome instruments

• November 3, 2016
  

  Safety, Dosing, and Pharmaceutical Quality for Studies That Evaluate Medicinal Products (Including Biological Products) in Neonates

  Ward RM, Benjamin D, Barrett JS, Allegaert K, Portman R, Davis JM, Turner MA, and the International Neonatal Consortium. Safety, Dosing, and Pharmaceutical Quality for Studies That Evaluate Medicinal Products (including Biological Products) in Neonates. Pediatric Research. 2017 Mar 1....